Evidence map›Paper›PMID 42339124›Full record

ArticleFrontiers in oncology2026

Case Report: Post-transplant lymphoproliferative disorder mimicking Baló's concentric sclerosis.

Xiaofeng Xiong, Ting Zhang, Yu Li, Hongtao Jin, Xintao Lei, Yanzhen Jiang, Qiaoying Huang, Qianhui Xu, Ying Huang

Abstract readCase Reports
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Xiaofeng XiongDepartment of Neurology, Shenzhen People's Hospital, The Second Clinical Medical College, Jinan University, Shenzhen, China.
Ting ZhangDepartment of Neurology, The First Affiliated Hospital (Shenzhen People's Hospital), School of Medicine, Southern University of Science and Technology, Shenzhen, China.
Yu LiDepartment of Neurology, Shenzhen Third People's Hospital, Shenzhen, China.
Hongtao JinDepartment of Pathology, Shenzhen People's Hospital (The First Affiliated Hospital, Southern University of Science and Technology; The Second Clinical Medical College, Jinan University), Shenzhen, China.
Xintao LeiDepartment of Pathology, Shenzhen People's Hospital (The First Affiliated Hospital, Southern University of Science and Technology; The Second Clinical Medical College, Jinan University), Shenzhen, China.
Yanzhen JiangDepartment of Neurology, Shenzhen People's Hospital (The First Affiliated Hospital, Southern University of Science and Technology; The Second Clinical Medical College, Jinan University), Shenzhen, China.
Qiaoying HuangDepartment of Neurology, Shenzhen Bao'an Shiyan People's Hospital, Shenzhen, China.
Qianhui XuDepartment of Neurology, Shenzhen People's Hospital (The First Affiliated Hospital, Southern University of Science and Technology; The Second Clinical Medical College, Jinan University), Shenzhen, China.
Ying HuangDepartment of Neurology, Shenzhen People's Hospital (The First Affiliated Hospital, Southern University of Science and Technology; The Second Clinical Medical College, Jinan University), Shenzhen, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Post-Transplant Lymphoproliferative Disorder (PTLD) is a lymphoproliferative disease that occurs in recipients of solid organ or hematopoietic stem cell transplants, resulting from the malignant transformation of benign proliferative lymphoid or plasma cell tissue due to immunosuppression. As an immunodeficiency-associated lymphoproliferative disorder, PTLD can affect various organs, including lymph nodes, the gastrointestinal tract, lungs, kidneys, and the central nervous system. The overall prognosis is generally poor. This case report describes a 37-year-old female patient presenting with magnetic resonance imaging (MRI) findings mimicking Baló's concentric sclerosis (BCS). However, pathological biopsy confirmed a diagnosis of monomorphic Primary Central Nervous System PTLD (PCNS-PTLD). The patient was treated with immunosuppression reduction combined with rituximab plus lenalidomide which led to a partial remission. Both PTLD and Baló's concentric sclerosis exhibit significant improvement with high-dose corticosteroid therapy, which can complicate the differential diagnosis. This report aims to summarize the clinical features of a case of PCNS-PTLD that mimicked Baló's concentric sclerosis to enhance the early recognition and diagnosis of PCNS-PTLD.

Indexed as

Baló’s concentric sclerosisCNSdifferent diagnosispost-transplant lymphoproliferative disorderPTLD

Identifiers

PMID42339124
PMCPMC13283889

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.